Identification of prognostic molecular features in the reactive stroma of human breast and prostate cancer.
about
Genetic instability in the tumor microenvironment: a new look at an old neighborInsidious changes in stromal matrix fuel cancer progressionInteractions between tumor cells and microenvironment in breast cancer: a new opportunity for targeted therapyWhy the stroma matters in breast cancer: insights into breast cancer patient outcomes through the examination of stromal biomarkersClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap.Microenvironmental regulation of therapeutic response in cancerYes-Associated Protein Expression Is Correlated to the Differentiation of Prostate Adenocarcinoma.Expression changes in the stroma of prostate cancer predict subsequent relapseValidation of COL11A1/procollagen 11A1 expression in TGF-β1-activated immortalised human mesenchymal cells and in stromal cells of human colon adenocarcinoma.Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13.Sustained β-catenin activity in dermal fibroblasts promotes fibrosis by up-regulating expression of extracellular matrix protein-coding genes.The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell nichesIntegrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer.Modelling circulating tumour cells for personalised survival prediction in metastatic breast cancerIdentification of therapeutic targets for breast cancer using biological informatics methods.The stromal genome heterogeneity between breast and prostate tumors revealed by a comparative transcriptomic analysis.Molecular characterization of Gleason patterns 3 and 4 prostate cancer using reverse Warburg effect-associated genesLaser Capture Microdissection as a Tool to Study Tumor Stroma.Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activationThe stroma-a key regulator in prostate function and malignancyFibroblasts as architects of cancer pathogenesisStromal Activation by Tumor Cells: An in Vitro Study in Breast CancerMarkers of breast cancer stromal fibroblasts in the primary tumour site associated with lymph node metastasis: a systematic review including our case series.Stromal Androgen Receptor in Prostate Cancer Development and ProgressionSystematic analysis of tumour cell-extracellular matrix adhesion identifies independent prognostic factors in breast cancer.Asporin is a stromally expressed marker associated with prostate cancer progressionProteomics of human prostate cancer biospecimens: the global, systems-wide perspective for protein markers with potential clinical utility.COL11A1/(pro)collagen 11A1 expression is a remarkable biomarker of human invasive carcinoma-associated stromal cells and carcinoma progression.Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.3'UTR shortening and EGF signaling: implications for breast cancer.Intra-tumoural stromal morphometry predicts disease recurrence but not response to 5-fluorouracil - results from the QUASAR trial of colorectal cancer.Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.SSeCKS/AKAP12 scaffolding functions suppress B16F10-induced peritoneal metastasis by attenuating CXCL9/10 secretion by resident fibroblasts.Comment on: The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer.Identifying tumor promoting genomic alterations in tumor-associated fibroblasts via retrovirus-insertional mutagenesis.Integrated Bioinformatics Analysis of Potential Biomarkers for Prostate Cancer.Common Subcluster Mining in Microarray Data for Molecular Biomarker Discovery.Identification of common key genes in breast, lung and prostate cancer and exploration of their heterogeneous expression.
P2860
Q26801374-D533A1AC-A1C4-4F42-BB5C-4AC57A28A7AAQ26851261-E1B1D1EB-0A12-4140-9149-569B91EB38F2Q27012888-07FE9F4C-911E-4B63-8CF9-9BC2B25BC1C5Q27023385-79ED840F-25FD-4DB2-94CE-AEBA6B519121Q30950943-FF1AF13B-2A48-4F9D-A533-FBE874846C76Q33654609-E2CD5D7C-B420-4699-A64C-EB5BA084CBB9Q33925616-E689F41C-C5C3-45E9-8BE1-580D6B70B144Q34368873-BD643389-A648-418F-B6AE-C81D17C521B8Q34581858-6014DC91-BA3F-401A-A8B8-D21C7D23CD3AQ35008756-0D745301-2399-48E4-A4C2-5ADF8EB08EAFQ35171136-CEC06932-57CE-4630-9825-395BF35E2DF6Q35499809-E38A26AB-0ADD-4207-AD43-5ECE07069058Q35561695-B04706F4-7AAF-4DC7-917D-606C4AF8EE92Q35610546-87B5C137-F946-4FE6-91F3-932EE1D33034Q35726382-4C3FF30E-5535-4A70-A62D-2C127DFCD7FAQ35832205-F198139F-6DDA-4EAE-AD28-474EE4AB9F0FQ36010440-7E9C3FE5-CA32-46EE-B9AF-BCDD2791A19AQ36118789-9C6242FA-208B-41FB-A720-521C3F9367A3Q36140754-152E2835-3160-4F38-B7D4-5288C13B3907Q36245519-555FA0EB-E8FE-4164-B990-11CE1272998FQ36544603-A71501CD-85AB-4D04-A3D0-D164AFD2D6A6Q37017028-627ABC5B-73E8-4ADB-A72B-C8AFF7397122Q37178453-4B60683B-DF5F-4A1A-AE69-A320B1CD6B8DQ37214284-361341D2-9F62-4435-BB8D-6705D7B487C4Q37386814-4A6686BB-6E1C-4F18-BFFD-E41B68420228Q37629551-783AED4C-29E2-4790-B26C-EFC2C8901E63Q37665209-46DDC6A2-FF47-477D-A157-2F2B7589584FQ37707965-06EF3E37-0E7D-4AFD-B79B-4722260837CCQ38132914-144FDD0D-3EEC-4237-8968-A9EE07FD7A77Q38374291-BEA6FF02-9C05-4042-A4DA-0CE15AF00688Q38429979-DC6236E3-31F2-4085-9C95-71FD05960569Q38833441-C0B61573-C51D-4B99-B36E-E354BBCCA2EBQ40489826-F6D1FE9F-5281-4635-9BE2-8AC49637468EQ40811309-7FBD21FF-0893-4058-B347-A8A40CD2F89EQ42378427-F85760C3-5A2F-4B75-8B53-0D6103117A38Q43171997-849104CE-E2E7-4573-AD85-D95E45A2CB8EQ47144483-386A0707-A83D-49BC-92DE-B32E25E56ACFQ47272075-0FA4200F-35F0-4656-9F15-CE518A1E2C33Q47816021-0FE8F569-7903-4C35-A5DF-42C4E27FC864Q49587340-C344B9A5-8E8B-48BB-A7AB-C2383C25CA00
P2860
Identification of prognostic molecular features in the reactive stroma of human breast and prostate cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Identification of prognostic m ...... an breast and prostate cancer.
@ast
Identification of prognostic m ...... an breast and prostate cancer.
@en
type
label
Identification of prognostic m ...... an breast and prostate cancer.
@ast
Identification of prognostic m ...... an breast and prostate cancer.
@en
prefLabel
Identification of prognostic m ...... an breast and prostate cancer.
@ast
Identification of prognostic m ...... an breast and prostate cancer.
@en
P2093
P2860
P1433
P1476
Identification of prognostic m ...... an breast and prostate cancer.
@en
P2093
Anne Planche
Carlo Fusco
Ivan Stamenkovic
Jean-Christophe Stehle
Marina Bacac
Mauro Delorenzi
Paolo Provero
P2860
P304
P356
10.1371/JOURNAL.PONE.0018640
P407
P577
2011-05-18T00:00:00Z